Back to results
US 8,507,560 B2Granted
Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1H)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity
AssigneeAllergan, Inc.
InventorsRichard L. Beard, John E. Donello, Michael E. Garst, Veena Viswanath
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of treating a disorder associated with modulation of the FPRL-1 receptor which comprises administering a therapeutically effective amount of a pharmaceutical composition comprising a 3,4-dihydroisoquinolin-2(1H)-yl-3-phenylurea derivative.
Claims7
A method of modulating the N-formyl peptide receptor like-1 (FPRL-1) receptor comprising administering to a mammal in need thereof, a pharmaceutical composition comprising a therapeutically effective amount of at least one compound selected from:
Dependencies are inferred from the claim text.